Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
Clinical trial NCT06369259 · RECRUITING
Trial details
- NCT number
- NCT06369259
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2029-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.